Rigel Pharmaceuticals, Inc. Quarterly report pursuant to Section 13 or 15(d)

Lease Agreements (Tables)

9 Months Ended

Sep. 30, 2017

The changes in the liability related to the sublease agreement for the nine months ended September 30, 2017 were as follows (in thousands):


Balance at January 1, 2017	$	3,460
Increase in deferred liability		495
Accretion of deferred liability		141
Amortization of deferred liability		(2,848)
Balance at September 30, 2017	$	1,248